Additional MRI for initial M-staging in pancreatic cancer: a cost-effectiveness analysis.

Felix G GassertSebastian ZiegelmayerJohanna LuitjensFlorian T GassertFabian TollensJohann RinkMarcus R MakowskiJohannes RübenthalerMatthias F Froelich

Published in: European radiology (2021)

• Additional MRI of the liver for initial staging of pancreatic cancer results in lower total costs and higher effectiveness. • The economic model showed high robustness for varying input parameters.

Keyphrases

contrast enhanced
lymph node
magnetic resonance imaging
pet ct
diffusion weighted imaging
randomized controlled trial
systematic review
computed tomography
magnetic resonance